PJA1 Antibodies

Santa Cruz Biotechnology delivers a wide array of PJA1 monoclonal antibodies for research applications. PJA1 monoclonal antibodies are compatible with western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). PJA1 functions as a key regulator in protein degradation and cellular signaling pathways, maintaining cellular homeostasis. The ubiquitin-proteasome system involvement of PJA1 demonstrates significance in biological processes, including cell cycle regulation and stress response mechanisms. Understanding PJA1 functionality provides insights into cancer development and neurodegenerative conditions. Research utilizing PJA1 monoclonal antibodies enables detailed investigation of cellular pathways and molecular mechanisms. Exploring PJA1's role in disease progression helps advance therapeutic strategies. PJA1 monoclonal antibodies support precise detection and characterization in multiple experimental approaches. Santa Cruz Biotechnology monoclonal antibodies for PJA1 contribute to advancing scientific understanding and therapeutic development across the research community.